Today: 16 April 2026
Xero share price jumps as ASX tumbles — what to watch before the next trade
4 March 2026
1 min read

Xero share price jumps as ASX tumbles — what to watch before the next trade

Sydney, March 4, 2026, 18:39 AEDT — Market closed.

  • Xero closed up, bucking the sharp selloff that hit Australian shares.
  • Xero’s latest data points to a slowdown in U.S. small-business sales growth toward the end of 2025, but payment times saw an uptick.
  • March 5 arrives with traders eyeing oil, interest rates, and looking ahead to Xero’s results in May.

Xero Ltd (ASX: XRO) picked up 2% on Wednesday, finishing at A$80.46. Not many blue chips managed gains, with the S&P/ASX 200 falling 1.94% by the close.

This is important right now: Xero is close to the heart of the local tech scene. Rate moves and risk shifts hit it hard—it reacts quickly, and tends to pull sentiment along in its wake.

Investors are facing a calendar snag—little in the way of new earnings, but noise is everywhere. Xero is pushing out updates impacting both its ecosystem and its story on U.S. growth, just as markets wrestle with the next move for interest rates.

The previous session saw the stock finish at A$78.86, having swung from A$78.01 up to A$80.68, according to Reuters data.

Australian GDP jumped 0.8% in the December quarter, up 2.6% on the year—marking the sharpest annual gain in almost three years, according to Wednesday’s figures. Stephen Smith at Deloitte Access Economics said the data keeps the central bank “on high alert,” raising the odds for a rate move in May. IG’s Tony Sycamore noted consumers remain wary. Reuters

Growth stocks often take a hit when rates rise—future profits just don’t look as shiny to investors. Software has felt the pressure, fundamentals aside.

Xero on Tuesday released new U.S. small-business figures: sales growth averaged 2.4% year-on-year for 2025, but dipped to just 0.9% in the December quarter. Late payments came down, averaging 7.8 days. “Conditions can shift,” company economist Louise Southall noted. North America managing director Andrew Kanzer flagged policy uncertainty as the top risk. Xero

Xero has rolled out a fresh developer charging structure, replacing revenue-sharing for some third-party apps with tier-based fees calculated on customer connections and API data usage — that’s the pipeline enabling apps to tap into Xero’s data. The company also confirmed its revised terms now ban using Xero API data for training AI or machine-learning models.

But the path forward isn’t certain. Higher borrowing costs, or a sudden spike in oil, might put pressure on small businesses and curb spending on subscriptions and extras. If developers push back against those rising costs, the platform narrative could get messier.

Thursday, March 5, brings the question: will the risk-off vibe stick around in global markets, weighing on local tech? Xero’s key date ahead is May 14, when it delivers FY26 full-year results.

Stock Market Today

  • Amerigo Resources Q1 2026 Results Signal Capital Allocation Shift with Dividend and Buyback
    April 15, 2026, 9:21 PM EDT. Amerigo Resources Ltd. (TSX:ARG) reported Q1 2026 operating results reaffirming full-year copper and molybdenum production guidance. The company completed a C$5.9 million share buyback and declared a C$0.16 per-share performance dividend payable in May 2026. Despite scheduled maintenance, cash costs trended below guidance, highlighting operational efficiency. Amerigo's single-asset strategy focuses on cash generation and capital returns, underscored by this combination of buyback and special dividend. Shares have risen but appear undervalued by roughly 30% against fair value estimates ranging from C$5.26 to C$9.15. However, recent insider selling adds risk. The firm's capital discipline and market positioning suggest investors watch copper prices, MVC execution, and future capital decisions closely.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Pro Medicus share price bounces after Tuesday slump as war fears hit ASX; what’s next for PME?
Previous Story

Pro Medicus share price bounces after Tuesday slump as war fears hit ASX; what’s next for PME?

Diageo share price today: DGE stock slips after HSBC downgrade — what investors watch next
Next Story

Diageo share price today: DGE stock slips after HSBC downgrade — what investors watch next

Go toTop